Doctors told ABC News Australia that patients who keep GLP-1 jabs or illegal peptide use from their surgical team could face serious consequences.
Recap by typeshit. Post by @abcnews_au on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
The experimental weekly shot targets three gut hormones at once. The reported results came in under a year of treatment, per the post.
A shared study finding tracks GLP-1 receptor agonist prescriptions among adolescents who qualified for weight loss surgery from 2017 to 2025.
Loading…